Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 19, 2011 06:30 ET | Source: QLT Inc.

QLT to Present at the UBS Global Life Sciences Conference

VANCOUVER, British Columbia, Sept. 19, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced that Bob Butchofsky, President and Chief Executive Officer, will be presenting at the...
September 14, 2011 06:30 ET | Source: QLT Inc.

QLT Receives Fast Track Designations for QLT091001 to Treat Both Leber Congenital Amaurosis and Retinitis Pigmentosa

VANCOUVER, British Columbia, Sept. 14, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced the Company's oral synthetic retinoid for retinal diseases, QLT091001, has been granted...
August 29, 2011 06:30 ET | Source: QLT Inc.

QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System

First reported demonstration of a clinically significant, prolonged (4 weeks) reduction in intraocular pressure (IOP) in glaucoma with an extraocular, minimally-invasive sustained release...
July 28, 2011 06:30 ET | Source: QLT Inc.

QLT Announces Second Quarter Results for 2011

VANCOUVER, British Columbia, July 28, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the second quarter ended June 30, 2011....
May 31, 2011 12:12 ET | Source: QLT Inc.

QLT Announces Issuance of U.S. Patent for Use of QLT091001 in Treatment of Inherited or Age-Related Retinal Diseases

VANCOUVER, British Columbia, May 31, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced the United States Patent and Trademark Office ("USPTO") has issued a key patent related...
May 05, 2011 06:30 ET | Source: QLT Inc.

QLT Announces First Quarter Results for 2011

VANCOUVER, British Columbia, May 5, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the first quarter ended March 31, 2011....
May 03, 2011 06:30 ET | Source: QLT Inc.

QLT Announces Positive Results From Phase 1b Trial of QLT091001 in Subjects With Leber Congenital Amaurosis

VANCOUVER, British Columbia, May 3, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX-V:QLT) ("QLT" or the "Company") announced today positive preliminary results from its Phase 1b proof-of-concept...
April 27, 2011 06:30 ET | Source: QLT Inc.

QLT Announces QLT091001 Presentation At ARVO

VANCOUVER, British Columbia, April 27, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that preliminary results from the Leber Congenital Amaurosis...
March 01, 2011 06:30 ET | Source: QLT Inc.

QLT Announces Fourth Quarter and Year End 2010 Results

VANCOUVER, British Columbia, March 1, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the fourth quarter ended December 31,...
February 23, 2011 06:30 ET | Source: QLT Inc.

QLT Chief Medical Officer Steps Down

VANCOUVER, British Columbia, Feb. 23, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the departure of Dipak Panigrahi, MD, Senior Vice President,...